Intrathecal administration of TGF-β2 resulted in the amelioration of autoimmune encephalitis, while transplantation of Tgfb2−/− neural precursor cells into mice with experimental autoimmune encephalomyelitis had no effect on immune response cell accumulation [97]. This evidence concerns the gene TGFB2 and experimental autoimmune encephalomyelitis.